Clinical Trial Update: Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating panitumumab in combination with bortezomib in advanced colorectal cancer was terminated; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• Panitumumab (panitumumab)

Snippet

Sponsor: Georgetown University | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-03-16